Literature DB >> 11469615

Dual test diabetes screening project: screening for poor glycemic control in a large workplace population.

A W Carter1, N Borchardt, M Cooney, D Greene.   

Abstract

The objective of this study was to assess the efficacy of a dual test blood glucose/fructosamine home monitoring system to screen individuals in the workplace for poor glycemic control. Screening values qualifying individuals for 90 days of additional monitoring were as follows: fasting blood glucose > or =126 mg/dL, casual blood glucose > or =140 mg/dL, and/or fructosamine <310 micromol/L. Subjects with positive values were provided access to classroom instruction by a Certified Diabetes Educator. The population consisted of 100 males and 177 females, ages 22-71 years, mean 49.7 years, with 12 males and 22 females reporting diabetes. Their ethnic backgrounds were 17.7% African American, 0.4% Asian, 1.8% Hispanic, 0.4% mixed, and 79.8% Caucasian reflecting the general United States population. A total of 26 males and 27 females had results indicating poor glycemic control. Of the known individuals with diabetes, seven of 12 males and 15 of 22 females had positive results. More males than females were unaware of their potential for diabetes but of those previously diagnosed with diabetes more females than males had poor glycemic control. A total of 31 subjects tested positive for blood glucose, 39 tested positive for fructosamine, indicating a 15.1% (p < 0.005) improvement in detection chances with fructosamine. Cost per subject including equipment, supplies, and labor was $18.13. Study results indicate that the addition of a fructosamine test improves screening accuracy for large groups of people while retaining ease of use and affordability.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11469615     DOI: 10.1089/15209150050501934

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  2 in total

1.  A review of glycated albumin as an intermediate glycation index for controlling diabetes.

Authors:  H Vernon Roohk; Asad R Zaidi
Journal:  J Diabetes Sci Technol       Date:  2008-11

2.  An analysis of the assessment of glycated hemoglobin using A1cNow+ point-of-care device compared to central laboratory testing--an important addition to pharmacist-managed diabetes programs?

Authors:  Alan W Carter
Journal:  J Diabetes Sci Technol       Date:  2008-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.